Cercar
18/10/2021
Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease
Ximelis, T, Marin-Moreno, A, Espinosa, JC, Erana, H, Charco, JM, Hernandez, I, Riveira, C, Alcolea, D, Gonzalez-Roca, E, Aldecoa, I, Molina-Porcel, L, Parchi, P, Rossi, M, Castilla, J, Ruiz-Garcia, R, Gelpi, E, Torres, JM, Sanchez-Valle, R. Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease. Alzheimers Research & Therapy. 2021; 13(1)DOI:10.1186/s13195-021-00912-6. PMID:34663460. IF:8.831(Q1/1D).
04/10/2021
Divergent connectomic organization delineates genetic evolutionary traits in the human brain
Bueicheku, E, Gonzalez-de-Echavarri, JM, Ortiz-Teran, L, Montal, V, Uquillas, FD, De Marcos, L, Orwig, W, Kim, CM, Ortiz-Teran, E, Basaia, S, Diez, I, Sepulcre, J. Divergent connectomic organization delineates genetic evolutionary traits in the human brain. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-99082-6. PMID:34608211. IF:4.997(Q2/3D).
26/09/2021
Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease
Barranco, N, Pla, V, Alcolea, D, Sanchez-Dominguez, I, Fischer-Colbrie, R, Ferrer, I, Lleo, A, Aguado, F. Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease. Translational Neurodegeneration. 2021; 10(1)DOI:10.1186/s40035-021-00263-0. PMID:34565482. IF:9.883(Q1/1D).
24/09/2021
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy
De Kort, AM, Kuiperij, HB, Alcolea, D, Kersten, I, Versleijen, AAM, Greenberg, SM, Stoops, E, Schreuder, FHBM, Klijn, CJM, Lleo, A, Claassen, JAHR, Verbeek, MM. Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy. Alzheimers Research & Therapy. 2021; 13(1)DOI:10.1186/s13195-021-00899-0. PMID:34560885. IF:8.831(Q1/1D).
01/09/2021
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
Tijms, BM, Gobom, J, Teunissen, C, Dobricic, V, Tsolaki, M, Verhey, F, Popp, J, Martinez-Lage, P, Vandenberghe, R, Lleo, A, Molinuevo, JL, Engelborghs, S, Freund-Levi, Y, Froelich, L, Bertram, L, Lovestone, S, Streffer, J, Vos, S, Blennow, K, Scheltens, P, Zetterberg, H, Visser, PJ, ADNI. CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals. Proteomes. 2021; 9(3)DOI:10.3390/proteomes9030036. PMID:34449748. IF:(Q/D).
01/09/2021
Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain
Ledreux, A, Thomas, S, Hamlett, ED, Trautman, C, Gilmore, A, Hager, ER, Paredes, DA, Margittai, M, Fortea, J, Granholm, AC. Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain. Journal of Clinical Medicine. 2021; 10(17)DOI:10.3390/jcm10173931. PMID:34501378. IF:4.964(Q2/4D).
01/09/2021
Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes
Horta-Barba, A, Pagonabarraga, J, Martinez-Horta, S, Busteed, L, Pascual-Sedano, B, Illan-Gala, I, Marin-Lahoz, J, Aracil-Bolanos, I, Perez-Perez, J, Sampedro, F, Bejr-Kasem, H, Kulisevsky, J. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes. JOURNAL OF NEUROLOGY. 2021; 268(9)DOI:10.1007/s00415-021-10511-y. PMID:33704556. IF:6.682(Q1/2D).
01/09/2021
Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome
Montal, V, Barroeta, I, Bejanin, A, Pegueroles, J, Carmona-Iragui, M, Altuna, M, Benejam, B, Videla, L, Fernandez, S, Padilla, C, Aranha, MR, Iulita, MF, Vidal-Pineiro, D, Alcolea, D, Blesa, R, Lleo, A, Fortea, J. Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. ANNALS OF NEUROLOGY. 2021; 90(3)DOI:10.1002/ana.26178. PMID:34309066. IF:11.274(Q1/1D).